Home Journals Articles Updates About
CN
image
收藏切换
Biomimetic Gland Models with Engineered Stratagems
收藏切换
PDF
Xiang Lin1, 2, Lingyu Sun1, Minhui Lu1, Yuanjin Zhao1, 2, 3, *
Research. Vol 6 Article ID 0232
Less
收藏切换
Research. Vol 6 Article ID 0232
• Review Article •
Biomimetic Gland Models with Engineered Stratagems
Full
Xiang Lin1, 2, Lingyu Sun1, Minhui Lu1, Yuanjin Zhao1, 2, 3, *
Affiliations
  • 1Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.
  • 2Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang 325001, China.
  • 3Southeast University Shenzhen Research Institute, Shenzhen 518071, China.
Published: 2023-09-20 doi: 10.34133/research.0232
Outline
收藏切换

As extensively distributed tissues throughout the human body, glands play a critical role in various physiological processes. Therefore, the construction of biomimetic gland models in vitro has aroused great interest in multiple disciplines. In the biological field, the researchers focus on optimizing the cell sources and culture techniques to reconstruct the specific structures and functions of glands, such as the emergence of organoid technology. From the perspective of biomedical engineering, the generation of biomimetic gland models depends on the combination of engineered scaffolds and microfluidics, to mimic the in vivo environment of glandular tissues. These engineered stratagems endowed gland models with more biomimetic features, as well as a wide range of application prospects. In this review, we first describe the biomimetic strategies for constructing different in vitro gland models, focusing on the role of microfluidics in promoting the structure and function development of biomimetic glands. After summarizing several common in vitro models of endocrine and exocrine glands, the applications of gland models in disease modelling, drug screening, regenerative medicine, and personalized medicine are enumerated. Finally, we conclude the current challenges and our perspective of these biomimetic gland models.

Xiang Lin, Lingyu Sun, Minhui Lu, Yuanjin Zhao. Biomimetic Gland Models with Engineered Stratagems[J]. Research, 2023 , 6 (9) : 0232 - . DOI: 10.34133/research.0232
Full Text
Less
Introduction
Less
Glands are organs or tissues that secrete or excrete specific substances such as hormones, enzymes, mucus, sweat, and saliva, which are essential for the maintenance of normal functions of various systems and organs in the human body [1–3]. The formation of glands is a complex process involving differentiation and maturation of glandular epithelial cells [4]. Such process begins from the embryonic stage and continues through postnatal growth and maturation, regulated by a complicated network of signaling pathways and transcription factors [5–7]. In general, glands can be categorized into 2 major types: exocrine glands and endocrine glands. Exocrine glands discharge their products into ducts leading to either the body surface or a cavity, such as sweat glands, salivary glands, and mammary glands. Conversely, endocrine glands directly release their products into the bloodstream, including the thyroid gland, pituitary gland, and adrenal gland, followed by transportation to targeted cells throughout the body [8,9]. Because of their importance in maintaining normal physiological processes, the malfunction or disease of glands may induce a broad range of health issues, including diabetes, thyroid disease, and cancer [10–12]. Given that, the construction of biomimetic gland models in vitro is vital for revealing the underlying mechanism of the development and disease progression of glands [13,14]. During the construction process, various demands should be satisfied including the replication of the complex cellular and structural heterogeneity of actual glands, as well as the reproduction of microenvironments containing multiple chemical and mechanical cues [15,16].
Tremendous efforts have been devoted to developing biomimetic gland models from a biological perspective. To build in vitro models that accurately represent the actual glands, it is necessary to select the appropriate cell type referring to glands [17–20]. For example, the mammary gland contains both functional epithelial cells and muscle cells, while the liver consists of liver cells and hepatic stellate cells [21,22]. Based on the gland-derived cell models with secretory function in vitro, pharmacological and toxicological evaluation could be conducted by detecting the corresponding secretory products [23,24]. Although glandular cells can partially replicate certain gland functions in vitro, the simplification of gland models often fails to fully capture the critical shape and function features of the gland tissue [25,26]. In contrast, self-organized organoid models provide a promising solution to this challenge [27,28]. These models are developed from patient-derived stem cells or tumor tissues in a specific 3-dimensional (3D) extracellular environment, allowing the formation of miniaturized organoid models with similar characteristics of real glands, such as microscale size, together with genetic and epigenetic features [19,29,30].
Although bioengineered gland models have achieved great progress in recent years, it is still a challenge to completely reconstruct real dynamic and complex microenvironments of glands. Biomedical engineering provides a new approach to simulate the internal environment of gland tissue, taking advantage of the engineered biomaterial scaffolds and microfluidics [31–34]. In this strategy, the scaffolds with gland similar architectures could provide topological cues to support cell growth and differentiation, while the microfluidic system could simulate the in vivo fluid microenvironment for providing spatial and temporal control of physical and mechanical cues [35–38]. Hence, organ-on-a-chip devices combined with biomimetic scaffolds can accurately reproduce physiological and pathophysiological processes of glands at the organ level [39–43]. Recently, the U.S. Food and Drug Administration has gradually lifted restrictions on animal testing in preclinical drug trials and approved the broader use of human cell-derived organ-on-a-chip systems [44]. Therefore, these accurate biomimetic gland models have been gradually utilized to simulate the generation of different disease models, drug screening, regenerative medicine, etc.
Herein, we reviewed the development of in vitro gland models ranging from engineered stratagems to biomedical applications of them. After describing the methods of culturing mammalian gland-derived cells in different kinds of patterns, we focused on the achievement of functional modeling of gland models based on engineering strategies such as organoid and microfluidic technologies. Next, we introduced several common endocrine and exocrine gland biomimetic models. Subsequently, we outlined how understanding the interplay between structure and function in different glands can be harnessed for biomedical purposes, including tasks like disease modeling, drug screening, and tissue regeneration. Finally, we will discuss the remaining challenges and provide forecast on the future research directions of these biomimetic gland models.
In Vitro Gland Modeling
Less
Various culture methods have been used to profile and study the glandular microenvironment in vitro [45]. Combined with the transwell culture chamber, the single-layer gland structure can be separated from the culture environment to simulate the niche gland environment [46,47]. Dissociated glandular cells can be incorporated into various stromal scaffolds [48], including collagen gels, matrigel, or decellularized extracellular matrices to generate 3D structures for examining glandular function and structure in vitro [49–53]. Alternatively, cells can be reconstituted without the need of scaffolds to form multicellular aggregates using methods such as hanging droplet systems, U-wells, suspension cultures, etc. [54–56]. These biomimetic gland models generated in vitro include key cell types and exhibit basic functions. Based on the self-organization-based gland models and microfluidic systems, the derived organ-on-chip provides a wider range of microenvironmental complexity.
Two-dimensional patterns
As a pivotal role of glands, the examination of secretory function in in vitro glandular models has become a focal point of research [57,58]. Among various culture patterns, traditional 2-dimensional (2D) cell culture has been used not only to study different types of cells in vitro but also to model and test cell absorption, distribution, metabolism condition, and other functions [59,60]. The advantages of the 2D cell model system include convenient operation in the laboratory, lower costs, and wider ethical acceptance compared to using animal models. Considering this, in vitro gland models for hepatotoxicity studies often rely on 2D cell culture [61,62]. Because this method cannot maintain constant concentration of culture activity over a period of time, it is necessary to change the medium regularly to remove accumulated catabolites and renew nutrients for maintaining cell viability and function [63,64]. This allows the preservation of communication between different hepatocytes and liver-specific functions, enabling a wide range of applications, such as acute liver failure, drug interactions, etc. (Fig. 1A) [65]. However, a major drawback of single-layer models is the lack of reliability due to cell dedifferentiation and senescence over time.
Transwell cell culture is an invasion assay technique that enables crosstalk between different layers of cells, by seeding cells in the upper or lower chamber. Because the membrane between chambers is permeable (0.4 to 8 μm), the components in the lower layer of the culture medium could affect the cells in another chamber (Fig. 1B) [66]. Thus, this approach enables improved examination of material transfer, cell–cell interactions between disparate chambers, and related phenomena (Fig. 1C) [66]. This unique culture technique can also be used to study the secretory function of glandular cell monolayers. During lactation, mammary acini produce a diverse array of milk components. The establishment and maintenance of cellular polarity within these acinar structures are critical for the normal lactation pathway of mammary epithelial cells, allowing for the efficient synthesis and secretion of milk constituents. To mimic these processes, the transwell technology can establish a concentration gradient in the same culture system, taking advantage of the tight junction (TJ) between cells to explore the secretion (Fig. 1D) [67]. TJs between monolayer cells prevent the unidirectional diffusion of secreted milk components, together with the external reabsorption of nutrients such as amino acids and lactose by epithelial cells. Apical secretory function with polarity is mimicked in vitro by using TJs to segment the distinct apical and basolateral regions.
Three-dimensional scaffolds
Modeling the intricate structure of glands outside of their natural environment poses a challenge due to their highly branched and multicellular organization (Fig. 2A) [68,69]. To replicate this complexity, the extracellular matrix (ECM) provides a 3D structure comprising decellularized proteins, both fibrous and non-fibrous, that surround cells in multicellular organisms (excluding circulating fluid) [70,71]. The ECM plays a critical role in both embryonic development and cellular homeostasis, and has wide-ranging implications for tissue engineering and regenerative medicine [72]. Unlike 2D layers, the use of 3D scaffolds enables the recreation of the gland's native ECM properties, including their physical, biochemical, and mechanical features, which further affects cell growth and function [73,74]. The materials used to prepare 3D scaffolds are usually collagen, alginate, and other hydrogels [75–77]. These hydrogels are polymers that retain large amounts of water within their 3D structure, which is crucial for maintaining the integrity of cells and tissues. To achieve in vitro mimicry of the ECM, various hydrogels, including matrigel and collagen derivatives, have been employed to cultivate mammalian cells. Hair follicle morphogenesis is a typical model of glandular development. Kageyama et al. [69] reported that they achieved large-scale in vitro fabrication of cells through self-assembly in collagen. The randomly distributed unicellular aggregates were formed during the first 3 days of the culture period, which then separated spatially from each other, exhibiting morphological features typical of hair follicles (Fig. 2B).
In particular, the emerging 3D bioprinting technology could combine stem cells with differentiation potential to generate massively replicable glandular spheroids [78,79]. For instance, dermal microvascular endothelial cells were employed to create vascular niches by crafting a sacrificial template from poly (ε-caprolactone) (Fig. 2C and D) [80]. The model enables the in vitro development of vascularized gland morphogenesis that closely mimics physiological conditions. With the combination of microarrays, such biomimetic model could further be employed to study the development process of glands in vitro and the mechanism of reciprocal regulation. However, the pre-structured scaffold's architecture may impede the mimicry of tissue and glandular morphogenesis. In addition, the generation of dynamic luminal structures within these scaffolds remains challenging. These problems pose a crucial hindrance to glandular cell morphogenesis and physiological secretory functions, which necessitate the presence of fluid shear forces.
Microfluidic platforms
Microfluidic platforms have emerged as powerful tools for creating in vitro models of various biological systems, including gland models. These platforms enable researchers to mimic the complex microenvironment of glands and study their functionality, response to stimuli, and disease mechanisms in a controlled and precise manner. The proper functioning of glands is inseparable from a strong blood circulation system [81,82]. In order to construct glands with accurate physiology, it is important to examine the multilevel structure of the target gland, as glandular cells do not function well in an unchanging culture substrate [83,84]. For example, alveoli consisting of distinct epithelial and endothelial cells include different microenvironments, such as the gas–liquid interface and liquid–liquid cross-section (Fig. 3A) [85]. For the construction of circulatory systems, microfluidic culture technology offers the possibility to address all these challenges, whether in 2D or 3D culture. Organs-on-a-chip devices allowed the culture of living cells under fluid flow, which can recapitulate physiology and pathophysiology at the organ level with high fidelity. These physiological processes can be explored in different glandular culture models with the aid of microfluidic systems.
The incorporation of microfluidics into 3D cell culture systems enables the delivery of controlled mechanical, chemical, and biological signals [86–88]. Several methods have been suggested for controlling the spatial and temporal characteristics of cellular microenvironments [89]. These techniques encompass adjustments in stiffness, micropatterning, 3D arrangements, and concentration gradients [90–92]. Specifically, cultured endothelial cells can be induced to differentiate in a chamber, through applying physiological shear stress and specific signaling stimuli. Similarly, functional glandular cells seeded on viscoelastic ECM gels can self-organize into polarized acinar structures [60]. Fluid shear stress brought about by fluids can promote the maturation of glandular tissues in vitro, while the development and function of glands are restricted in static culture (Fig. 3B) [93]. For example, the gene expression with the assistant of microfluidics observed in organoids composed of renal filtration-associated epithelial cells reflects the same condition during filtration in vivo (Fig. 3C) [93]. The maturity of the adult kidney is relatively low. Under high fluid flow, the cultivation of in vitro kidney organoids results in improved vascularization during the process of nephrogenesis.
Self-organizing organoids
The progress in stem cell therapy and tissue regeneration has facilitated the development of self-organizing organoids that recapitulate the structure and function of native tissues [94,95]. These 3D structures arisen from the spontaneous assembly of stem cells under optimized culture conditions could promote cell–cell and cell–ECM interactions [96–98]. The growth factors, ECM components, and mechanistic cues that drive organoid formation are carefully selected and tailored to the specific tissue type being modeled [99]. Besides, self-organizing organoids provide several advantages over traditional 2D cell culture and animal models for investigating glandular diseases and drug responses [100,101]. Firstly, they better replicate the intricate 3D structures and cellular heterogeneity of native tissues, enabling more precise modeling of disease mechanisms and drug effects [102,103]. Secondly, patient-derived stem cells can be utilized for developing personalized medicine approaches, and the investigation of rare or genetic disorders that are difficult to simulate in animals [104,105]. Lastly, self-organizing organoids can be readily scaled up for high-throughput drug screening and toxicology testing [106,107].
Self-organizing organoids have been used to mimic a range of glandular tissues, including liver, pancreas, salivary glands, and mammary glands. These organoids can recapitulate key aspects of gland development and function, including tissue architecture, cellular heterogeneity, and physiological responses to hormones and drugs (Fig. 4A and B) [108,109]. They are spherical collections of self-organizing cells that resemble natural tissues and exhibit organ function and 3D structure. Organoids have several inherent advantages over traditional models, including the establishment of macroscopic structures similar as in vivo tissue in complex 3D environments. Besides, the crosstalk between organoid cells can enhance the similarity to podocytes in vivo compared with traditional 2D culture methods. The 3D environment is critical not only during the differentiation process but also in maintaining the differentiated state, as organoid-derived podocytes de-differentiate in a 2D environment. Interestingly, when studying the functional effects of some viruses on the gland, human organ model systems have some unique advantages compared to animal models. Since the COVID-19 pandemic, human airway organoids faithfully mimic human airway epithelial cells, thus providing a platform for rapid detection of infectivity of emerging influenza viruses (Fig. 4C) [110]. A laboratory-generated salivary gland model derived from human-induced human induced pluripotent stem cells (hiPSCs) was found to be permissive to COVID infection. The findings indicate that salivary glands exhibit developmental characteristics similar to those observed during embryonic stages and can serve as a valuable tool for investigating gene function in development. Notably, the in vitro salivary gland model sustained replication of the COVID virus, suggesting its potential utility in studying viral infection mechanisms. Therefore, organoids are promising models for studying glands in vitro.
Endocrine and Exocrine Gland Models
Less
Glands are categorized into endocrine or exocrine types: endocrine glands release their secretions, including hormones, directly into the bloodstream, whereas exocrine glands secrete substances into body cavities (such as the mouth) or external surfaces (like the skin) [111–113]. In recent years, in vitro glandular models have garnered extensive attention as a substitute for animal models in investigating glandular diseases [114,115]. These models are highly sought-after for their potential in drug development and for studying glandular physiology, as they provide a controllable and reproducible environment for investigating the physiology and pathology of glands in a setting that mimics the human body [116,117]. The process of constructing engineered gland models involves a combination of techniques including cell culture, biomaterials, and microfabrication. Various methods have been employed to create glandular structures such as 3D printing, microfluidics, and self-assembly, which offer the ability to investigate glandular secretion, morphogenesis, and cellular interactions [19,118]. Furthermore, the incorporation of human stem cells and patient-derived cells in these models has demonstrated promising outcomes for simulating glandular diseases [119,120]. However, further research is necessary to enhance the fidelity of these models to in vivo systems. Here, we provide an overview of current commonly established in vitro glandular models for both endocrine and exocrine glands (Table).
Endocrine gland
Thyroid
The thyroid glands are mainly consisted of follicular cells and parafollicular cells (C cells) [121]. Upon receiving the stimulation of thyroid-stimulating hormone (TSH) secreted by the thyroid gland, the follicular cells in the inner layer would synthesize iodized thyroglobulin (Fig. 5A) [121]. The generated TSH would be degraded in the thyroid cells, and the remaining hormone enters the blood circulation. Former research on the thyroid mostly focused on hormone metabolism and iodide metabolism in animal models. In recent years, in order to simulate this metabolic process in an in vitro thyroid model, it is crucial to establish cultures derived from monolayer cells, or supplemented with TSH-containing medium and generate 3D acinar structures. Romitti et al. [122] have reported a novel technique, as depicted in Fig. 5B to D; they utilized stem cells with reprogrammed and modified signaling pathways to produce a functional human thyroid gland in vitro that can mimic the gland's function. The researchers demonstrated the creation of transplantable thyroid organoids derived from human embryonic stem cells. These organoids successfully reinstated plasma thyroid hormones in mice with an absent thyroid gland. Notably, follicular cells can form 3D acinus-like structures regardless of whether the 3D culture substrate is matrigel or collagen; although organoids have been successful in replicating the complex structures and functions of various organs, they still lack a crucial component—vascularity. To ensure that thyroid organoids are truly functional, both further vascular development and indeed enhanced maturation of the organoids are required. To promote vessel formation after (xeno) transplantation, vessel-like structures could be constructed, and in vitro biomaterials can also be utilized to create 3D culture systems that incorporate both tissue-derived organoids and vascular networks.
Tumor gland models can help researchers better understand cancer biology, test potential therapies, and develop new treatment strategies. Although there are fewer cancers generated by C cells, their prognosis is worse than that of small papillary carcinomas due to their low degree of differentiation. Medullary thyroid cancer makes up around 5% of all thyroid cancer cases, predominantly impacting C cells rather than follicular cells. So far, studies on the establishment of thyroid C cells in vitro are limited. In this scenario, Kwaku detailed an approach to construct a model for thyroid C cells. Here, human embryonic stem cells undergo progressive differentiation into cells resembling thyroid C cells, both in monolayer and within 3D matrigel culture environments [123]. The procedure entails a stepwise application of interferon as part of hormone treatment, mirroring the developmental sequence of the embryonic thyroid. Moreover, aside from quantifying the expression of C cell and related follicular lineage markers using qPCR (quantitative polymerase chain reaction) and immunolabeling, these cells exhibited functional attributes. This was evidenced by their ability to release calcitonin upon calcium stimulation, a trait confirmed through enzyme-linked immunosorbent assay during in vitro experiments.
Adrenal gland
In recent years, although researchers had gained much progress about human adrenal development and function from human (genetic) disease, the studies in adrenal gland have been hampered due to its distinctive structure and functions [124–126]. Only higher primates like monkeys share a similar structure and function of the adrenal cortex to humans, whereas rodents exhibit marked structural and functional differences. Therefore, there are many limitations when using animals such as mice as models for building in vitro models. Much of the current knowledge about adrenal development comes from mouse models, yet we still do not understand the intricate details of fetal adrenal development and function. According to existing studies, the adrenal gland is a polyendocrine organ with a mesenchymal cortex producing steroids and an endocrine medulla producing catecholamines of neuroendocrine origin [127–129]. Supported by a pool of stem/progenitor cells, this gland has a strong regenerative capacity, enabling it to maintain physiological regulation and meet hormonal demands.
Until now, benefiting from the single-cell sequencing technologies, spatiotemporal gene expression profiling of human fetal material has provided additional insights into developmental pathways. Besides, it is also a hot topic to construct in vitro models by combining various biomaterials and reprogrammed hiPSCs. Poli et al. [130] have created an adrenal gland model using fetal adrenal specimens from various gestational cycles. These cells demonstrated the ability to maintain their developmental processes in vitro and expressed markers indicative of primitive fetal organs, including the zona pellucida. Additionally, the cells spontaneously organized into 3D organ-oids with structural similarities to fetal glands. While this in vitro human adrenal system is preliminary in nature, it represented a unique opportunity for investigating the pathophysiological mechanisms underlying rational adrenal remodeling, organ hypoplasia and hyperplasia, and cancer.
Gonad
Prior knowledge about human gonads was largely obtained through histological analysis of tissue sections. Recently, Yamaguchi et al. [120] (Fig. 6A) used modeled slices of human endometrial tissue to study its morphology using 3D immunohistochemistry and layer analysis. Their findings showed that endometrial glands formed a tufted network in the basal layer and extended horizontally along the muscle layer. This in vitro approach can be used to assess uterine diseases such as adenomyosis and observe the affected tissue's 3D morphology. However, conducting research on human embryonic gonads is hindered by ethical and legal constraints and limited tissue availability. To overcome these limitations, in vitro models using stem-cell-derived gonads are needed to further explore the mechanisms underlying the development of gonads, the appearance of distinct cell types, and the shaping of tissues.
Human pluripotent stem cell (hPSC)-based organoids are 3D structures that mimic the complexity and functionality of human organs and tissues. These structures have shown great potential for constructing developing organs and tissues, as well as for modeling human diseases. In recent years, hPSC organoids have emerged as a powerful tool for studying the early stages of human reproductive development. With specific culture conditions, hPSCs can differentiate into different cell types, including those that form the gonads. This offers a unique opportunity to study the pathways that lead to the formation of male and female reproductive organs. Pryzhkova et al. [131] (Fig. 6B) presented a novel approach to studying tissue and organ development in vitro using 3D organoid technology of hPSCs. The researchers used suspension bioreactors to culture hPSC organoids, which allowed them to simulate the early stages of human reproductive development. The organoids were able to self-organize and differentiate into cells that express characteristic gonadal markers, indicating the potential of organoid technology for simulating gonad development. In addition, the researchers studied the influence of vascular cells on testis-specific tissues and successfully detected Hedgehog-BMP regulatory signals. This is important because these signals play a critical role in gonad development. The results showed that activated cells expressing tissue-specific morphogenesis also emerged in culture, indicating that the organoid technology is capable of simulating complex organogenesis. The ability to study the development of human reproductive organs using hPSC organoids has important implications for understanding the underlying mechanisms of reproductive disorders and for developing new therapies to treat them. In the future, this technology could also be used to generate transplantable tissues and organs for patients who require them.
The precise role of cervical epithelium in maintaining cervical integrity during infection and inflammation in gynecological diseases remains poorly understood. To investigate cell–cell interactions, Ahn et al. [132] (Fig. 6C) developed an endocervical epithelial organ-on-a-chip (EOC). The system consisted of 2 co-culture chambers connected by microchannels, allowing for the recapitulation of both endocervical and epithelial structures. Furthermore, the team evaluated the interactions between cells from different regions, together with their influence on maintaining cervical integrity in response to inflammatory stimuli. Co-culturing of extracervical and endocervical cells facilitated the migration of both types of epithelial cells within the microchannels. In comparison with the untreated control group, the inflammatory factor stimulation group demonstrated increased apoptosis, necrosis, and senescence of cervical epithelial cells, as well as increased production of pro-inflammatory cytokines. The EOC system serves as an in vitro model that mimics the exocervical and cervical epithelial regions of the cervix, which has the potential to be a powerful tool for research in obstetrics and gynecology. For example, it can be used to study cervical remodeling during pregnancy and childbirth, as well as the dynamics of cervical epithelial cells in benign and malignant lesions of the cervix.
Thymus
The thymus is a major lymphoid organ located in the upper mediastinum above the heart, which generates a diverse population of T cells to protect the body from pathogens (Fig. 7A) [133]. Campinoti et al. [134] used an engineered approach to generate in vitro thymic scaffolds in which the hematopoietic and functionalized fractions were hPSCs (Fig. 7B). The researchers created a scaffold composed of 2 cell types that can be expanded in a lab setting for extended periods. By combining thymic stromal cells and decellularized thymic ECM, they were able to reconstruct the thymus' natural anatomical surface. This structural modification enhanced T cell function and promoted the development of mature T cells in immunodeficient mice after transplantation. To summarize, constructing these in vitro models has practical implications for treating both innate and acquired immune diseases.
The development of thymus-based drugs for immune diseases is an emerging field. While xenogeneic animals are commonly used in preclinical research and drug discovery to mimic the human immune system, crafting operational human T cell compartments in experimental settings presents challenges due to variations between human and mouse thymus tissue. While transplanting human fetal thymus tissue into mice has shown potential for fostering robust T cell development, constraints related to tissue availability and ethical considerations hinder its widespread application. A recent investigation led by Zeleniak et al. introduced an alternative strategy involving human thymic organoids generated from induced pluripotent stem cells (iPSC-thymus). These organoids facilitated the efficient generation of substantial functional human T cell populations, capable of dampening humoral immune reactions, including inflammatory responses stemming from T cell receptor interactions (Fig. 7C) [133]. The authors outlined the feasibility of T-cell-mediated personalized immunotherapy based on individual patients. With further protocol refinement, it is possible that artificial thymuses could be bioengineered from patients' own iPSCs to treat immunodeficiency diseases in the future.
Exocrine gland
Liver
Metabolic diseases are becoming a major threat to health in modern society. In particular, the emerging obesity problem also reflects the increase of metabolic diseases, which is usually associated with abnormal liver metabolism [135,136]. Although the metabolism of different types of cells at the tissue level has been reported in succession, the specific structure and spatial morphology of many cells and organelles may also be related to metabolism at the single-cell or even subcellular level [137]. The latest research shows that the subcellular structure of the liver is quite different under the conditions of health and obesity, where structural regulation may be a prerequisite for metabolic programming [108]. For example, studies have shown the effect of increased endoplasmic reticulum tablets on the metabolism of obese mice (Fig. 8A) [138]. The metabolic factor that produces obesity is insulin resistance, which may cause serious lipid buildup in the liver, disrupting normal liver metabolism. Researchers have developed liver organ models using a variety of stem cell types, including adult stem cells, primary stem cells, and hPSCs. These platforms provide new opportunities to analyze the potential mechanism of metabolic diseases and develop personalized drugs.
In addition to obesity, high levels of alcohol consumption would lead to the prevalence of alcoholic liver disease that involved changes in liver function. To prevent this, inhibiting the process from fatty liver to fibrosis to cancer is also a thorny problem. Cho et al. [139] developed a liver-on-a-chip platform using bioengineered multicellular liver microtissues (Fig. 8B and C), incorporating 4 major types of hepatocytes (hepatocytes, endothelial cells, Kupffer cells, and stellate cells) to model human liver fibrosis resulting from nonalcoholic fatty liver disease (NAFLD). By including stellate cells in a fat-supplemented liver-on-a-chip model, they were able to observe elevated inflammatory responses and upregulation of fibrotic markers. This model provides a more natural representation of the pathology and chronology of disease compared to the transforming growth factor-induced liver fibrosis model, which can help in better understanding the mechanism of liver disease fibrosis progression and identifying new drug targets.
Salivary
As the branching process occurs, the ECM composition undergoes regional variation and plays a direct role in the maturation of salivary glands (Fig. 9A) [140]. Saliva has many essential functions, including helping to secrete digestive juices and maintaining human health through the secreted water, mucus, electrolytes, antimicrobial compounds, and various enzymes. As the first line of defense against many pathogens that enter through oral defenses, saliva can indicate a person's clinical condition. Researchers have employed various tissue engineering approaches to restore salivary secretion (Fig. 9B) [16], such as self-organization, low-adhesion culture plates, and 3D culture systems, to generate functional salivary gland organoids. Designing a fully functional salivary gland requires complex interactions between various cell types, including acini, ducts, and myoepithelial cells, as well as providing appropriate hormonal stimulation and vasculature to the gland. Therefore, engineered salivary glands must contain unique components and functions. For this purpose, understanding the mechanisms leading to the loss of secretion and involvement in the regeneration of functional organs remains the focus of current and future research.
It is anticipated that organoid culture models will prove suitable for in vitro demonstrations of coronavirus infection of salivary glands. Salivary glands are known to serve as reservoirs for various infectious diseases and have been identified as targets of severe acute respiratory syndrome coronavirus. To this end, Tanaka et al. [141] had successfully generated functional salivary gland organoids from hiPSCs by modifying the method used to induce organoids of salivary glands originating from mouse embryonic stem cells (Fig. 9C). These hiPSC-derived salivary gland organoids exhibited specific cell lineages, morphological characteristics, and physiological functions characteristic of salivary glands. The researchers had confirmed that coronavirus can infect and replicate within these salivary gland organoids. The in vitro model developed in this study provides a promising approach to investigate the salivary gland's role as a viral reservoir. hiPSC-derived salivary gland organoids, in particular, are a valuable tool for this purpose.
Sweat and sebaceous glands
The skin, being the largest and outermost organ of our body, plays a crucial role in protecting our body from external harms. This protective function is supported by its appendages, including hair follicles, sebaceous glands, sweat glands, and others (Fig. 10A) [142]. To date, the primary focus of in vitro skin-derived strategies has been on generating keratinocytes and fibroblasts from distinct cultures and then combining them to form a skin-like bilayer. Regrettably, these models fail to consider the inclusion of glands, which severely limits their biological and structural features. Consequently, designing a complete human skin model capable of generating all components, including appendages, continues to pose great challenges for the scientific community.
The sebaceous glands play a vital role in the skin's protective function by secreting oil into the ducts at the hair follicle junction, which aids in preventing water loss from the interfollicular epithelium and contributes to thermoregulation. To construct sebaceous glands, Lee et al. [142] have outlined a comprehensive procedure for cultivating hPSC populations into 3D in vitro culture systems, resulting in the development of hairy skin tissue (Fig. 10B). Through the implementation of precise culture conditions, PSCs were effectively directed to undergo differentiation into surface ectoderm. This ectoderm then gave rise to the epidermis and dermis within individual organoid units. With extended incubation, these skin organoids also proceeded to generate hair follicles. In the late stages of development, the skin organoids exhibited a highly biomimetic and complex structure, even including sensory nerves, and formed a cell composition and structure similar to fetal skin tissue at around 5 months. These skin organoids can be maintained in culture for up to 6 months. Additionally, they captured phase-contrast images of hair follicles in striking mouse skin organoids at different differentiation time points. Using these images, they were able to measure and quantify the length of the prominent pilosebaceous unit. This breakthrough makes organoids a useful tool for studying basic skin biology, model-ing diseases, and reconstructing or regenerating skin tissue in the future.
Patients with large skin defects often face challenges because of the limited number of stem cells present in the wound bed, which makes it difficult to form sufficient sweat glands. However, great progress has been made in patient-specific glandular tissue engineering by utilizing reprogrammed cells for regenerative therapy. In this regard, Sun et al. [143] presented a novel strategy for constructing human skin sweat glands in vitro (Fig. 10C). Initially, the researchers induced the expression of specific signals in human epidermal keratinocytes (HEKs) by binding them to a specific sweat gland medium, which efficiently converted the HEKs into sweat glands cells. These sweat glands cells exhibited the characteristic morphology, gene expression patterns, and functions similar to primary human sweat gland cells. Subsequently, sweat gland organoids with native sweat gland structure and biological properties were obtained by culturing sweat glands cells in a unique 3D culture system. Finally, these in vitro constructed sweat glands were successfully transplanted into a mouse skin injury model and developed into fully functional sweat glands in vivo. The regeneration of functional sweat gland organoids from reprogrammed HEKs represents a great advancement in personalized sweat gland regeneration and highlights the enormous translational potential of this approach for treating large skin defects.
Mammary
The morphological changes of mammary cells involve the occurrence of branching morphology, the formation of polar acini, etc. In vitro models have enabled the study of these phenomena, revealing the crucial role of different culture substrates in shaping the resulting morphologies (Fig. 11A, i and ii) [144]. For instance, mammary epithelial cells cultured in common matrigel tend to form acinar structures, whereas highly oriented collagen promotes elongation and branching morphogenesis of mammary ducts through the mechanical anisotropy generated by the fibrous domains. These observations were further supported by a micropatterning method developed by Nelson et al. in 2004. They determined that it is the geometry of the tubules that determines the location of the branches, while the sites with the lowest concentrations of local autocrine growth factors do not inhibit mammary morphology (Fig. 11A, iii and iv) [145]. To delve deeper into this phenomenon, Buchmann and colleagues employed models involving floating, attached, and partially detached collagen gels. These models were utilized to investigate the influence of the ECM on the morphogenesis of mammary epithelial cells (Fig. 11B) [146]. Their investigation unveiled a spatially and temporally controlled orchestration of epithelial morphogenesis within 3D collagen gels. Within this context, collagen emerged as a pivotal factor in the initiation of mammary duct formation and branching. Intriguingly, human mammary epithelial MCF10A cells embedded in collagen displayed acinar and tubular structures exclusively when the gel disengaged from the culture wells, facilitating cellular contraction. In stark contrast, MCF10A cells nurtured within attached gels adopted a sheet-like arrangement, reminiscent of epithelial cell structures grown on plastic surfaces, rather than those encountered within breast tissues. These findings emphasize the importance of carefully choosing culture substrates and geometry in in vitro models to accurately recapitulate mammary gland morphogenesis, providing valuable insights into the underlying mechanisms of this complex process.
The use of organoid technology has enabled the generation of ample quantities of breast cancer organoids, while human mammary epithelial cells can be cultured as organoid cultures without requiring immortalization. 3D in vitro cell culture models have been employed to deconstruct the structural and functional mimicry of mammary epithelial tissue. In a recent study by Rosenbluth et al. [144], it was observed that mammary epithelial cells exhibited self-organization into multiple structural types within organoid cultures. Plenty of the structures were observed to be acinar, possessing a lumen that was either isolated or associated with budding organoids. Additionally, solid spheres were also detected alongside branched tubular structures. The occurrence of branching or budding structures was noted in only 1 out of 102 organoids. The latter was seen predominantly in early passages, becoming less frequent with repeated dissociation and extended growth. Luminal cells, basal cells, or a combination of both cell types were found to be present within the organoids, indicating that the culture retained both basal and luminal cells.
Biomechanical factors, specifically stiffness, play a crucial role in limiting organoid generation. Epithelial cells struggle to form round and polar acinar structures in a 3D environment. Furthermore, differences in the spatial distribution of acini and ducts within the gel in matrices with differences in stiffness suggest that mechanical factors also influence the formation of mammary cell morphology (Fig. 11C and D) [147]. Collagen fibrous organization also contributes to epithelial morphogenesis, with cells most likely organizing collagen fibers by applying traction in early stages. This differentiated fibrous organization ultimately controls the formation of ductal or acinar structures by determining epithelial morphology. While the progression from tubular ducts to terminal spherical acini is a widespread occurrence in the developmental journey of advanced organisms, the mammary gland stands out as a unique illustration. It relies on distinct hormonal triggers across various developmental phases to orchestrate alterations in acinar configuration. This transformation, at its core, stems from a localized shift in intracellular tension within evolving human mammary organoids—shifting from anisotropic to isotropic tension. The morphological shift in alveolar generation within these organoids can be comprehended as a sprouting instability set in motion by a reduction in tension anisotropy. This intricate mechanism operates as a comprehensive feedback loop, ultimately influencing tissue shape through the lens of hydrodynamics.
The Application of Biomimetic Gland Models
Less
Biomimetic gland models have important potential for both basic and applied research. They replicate the intricate structural and functional characteristics of native glandular tissue, providing crucial insights into the cellular and molecular mechanisms governing gland development, function, and disease [148,149]. Specifically, they are useful for investigating the impacts of environmental factors, genetic mutations, drug treatments, toxins, pathogens, and other stressors on gland function [150]. Recent advancements in microfluidic systems and organ-on-a-chip technologies have introduced new bioinspired engineering approaches to miniaturize these interfaces. These advancements facilitate meticulous in vitro investigations into the orchestrated interplays among parenchymal and stromal cells within controlled surroundings. The progress in biomimetic engineering offers new prospects for studying glandular tissue and its complex interactions with the microenvironment in vitro, which can improve our comprehension of glandular development, function, and disease. Furthermore, these models are valuable for screening potential therapeutic agents for glandular diseases such as cancer, diabetes, and endocrine disorders, as well as for studying complex signaling pathways and crosstalk between different cell types within glandular tissue.
Modeling diseases
Animal models' inability to accurately predict treatment responses in humans raises concerns about their use in basic research. During the COVID-19 pandemic, researchers developed in vitro physiological models to replicate the effects of the SARS virus on various organs and glands [151]. Yang et al. [152] utilized directed differentiation of hPSCs to generate pancreatic endocrine cells and other organoids representing all 3 germ layers (Fig. 12A). Infected hPSC-derived pancreatic endocrine cells exhibited upregulation of apoptosis-associated genes and downregulation of cell survival-associated genes in response to SARS infection. The results suggested that SARS-CoV-2 induced chemokine induction in pancreatic endocrine cells, similar to what is observed in COVID-19 postmortem samples. The researchers also successfully infected primary human organoids mainly composed of cholangiocytes with SARS, providing evidence of the model's efficacy in studying the effects of diseases on human organs. Thus, this study successfully established an in vitro biomimetic gland model for investigating the impact of diseases on human organs, mitigating the issue of relying solely on animal models in basic research.
The mammary gland, a notably dynamic and well-vascularized tissue undergoing subsequent transformations in both regular developmental processes and disease conditions, demands a thorough examination of the intricate interplay between epithelial cells and the vascular system at the molecular and cellular levels. Co-culturing glandular epithelial cells with other cell types, such as stromal or endothelial cells, can provide researchers with a more comprehensive understanding of the complex interplay among these cell types and their contribution to glandular function. Kutys et al. [153] developed a 3D microfluidic platform that allows for the co-culture of human mammary ducts and perfused endothelial vessels (Fig. 12B and C). The framework faithfully replicated the consistent structural attributes of natural mammary tissue and its capacity to engage in diverse manifestations of branching morphogenesis. Using this system enables the simulation of mutations in specific disease signaling pathways, facilitating the observation of dramatic differences in morphogenetic and behavioral outcomes. Unlike traditional 3D acinar models where cells aggregate to form empty acini that undergo apoptosis, the recently devised platform stands apart. It adeptly captures the evolution and invasive tendencies of mammary epithelial cells across different developmental stages. This innovation provides a visual avenue for tracking alterations in cellular and tissue arrangements, the dynamics of tissue branching and invasion, and the functional transformation of the vasculature. Impressively, the model accurately reproduces distinct morphogenetic phenotypes in response to specific soluble growth factors, mirroring real-world observations and other systems. While the partial apical maturation of MCF10A cells might contribute to these outcomes, the exclusive morphogenic responses tied to growth factor sensitivity hint at an inherent diversity within mammary gland morphogenesis, further enriching our grasp of mammary gland development and the mechanisms governing its control in various diseases.
Drug screening
Advances in high-throughput screening for drug toxicity, drug response, and metabolic disease have been facilitated by the development of functional human stem organoids [154]. The in vitro gland model provides a valuable tool for evaluating the efficacy and toxicity of drugs, especially those that may affect glandular function [155–157]. Traditional cell culture systems lack the complex interactions and functional characteristics of native tissues, making them unsuitable for drug evaluation [158]. Engineered in vitro gland models, on the other hand, aim to recapitulate the architecture, cell composition, and functional properties of glandular tissues in a controlled laboratory setting. For instance, the lack of liver biopsies from patients with liver diseases, as well as suitable cell and animal models, hampers targeted drug strategies for corresponding diseases. As mentioned before, hepatic organoid systems have become attractive models for preclinical or clinical drug screening due to their similarity to liver tissue and their ability to screen drug effects on liver phenotypes before testing in patients [159–161].
Reduced salivation is a common side effect of various medications, which can be worsened by co-administration of multiple drugs. Additionally, radiation-based cancer therapies can lead to permanent loss of saliva, with a side effect of permanent impairment on salivary gland function. However, there is currently no appropriate in vitro model for conducting salivary gland experiments within normal radiation dose ranges. Additionally, formulating defensive strategies to avert the swift decline of the secretory acinar cell phenotype during cultivation has been a focus. To address this challenge, Song et al. [162] introduced a modular salivary gland tissue chip platform (Fig. 13A), which maintained the secretory acinar cell phenotype in vitro and provided a controllable microenvironment for long-term cell culture. These chips have been utilized for radiation response studies and for screening radioprotective drugs to alleviate xerostomia. Importantly, this methodology stands independent of stem cells or iPSCs, given that protocols for deriving salivary gland cells from iPSCs are still in the developmental phase. The outcome of this endeavor is a salivary gland tissue-on-a-chip system, which proves invaluable for conducting extensive and detailed screenings. Its application extends to mechanistic investigations and drug evaluation.
Parathyroid disease is a pathological condition characterized by abnormal calcium homeostasis and disturbances in parathyroid hormone secretion. The use of in vitro models may facilitate targeted therapy of parathyroid disease. In one study, Noltes et al. [163] created human parathyroid organoids to mimic human parathyroid tissue (Fig. 13B). Various organoids have been obtained by isolating and culturing glandular cells. The model demonstrates responses and correlated responses to changes in calcium concentrations and drug treatments. Under normal physiological conditions, parathyroid hormone secretion is negatively regulated by increased extracellular calcium levels. When exposed to high levels of calcium, human parathyroid organoids showed a significant reduction in parathyroid hormone secretion, compared to normal culture conditions. Subsequently, when human parathyroid organoids returned to basal calcium levels, a significant increase in parathyroid hormone secretion was observed. These findings suggest that human parathyroid organoids have a complete functional response. To assess the usefulness of patient-derived human parathyroid organoids in testing new therapeutic targets, validated therapeutic compounds were used to assess drug effects on human parathyroid organoid secretion. The results demonstrated that parathyroid hormone secretion was significantly reduced in parathyroid organoids with the treatment of various concentrations of cinacalcet compared to dimethyl sulfoxide controls. Additionally, the parathyroid organoids effectively recreated the genetic and protein profiles of the native tissue. This model provides a useful tool for investigating potential therapeutic targets and imaging agents for parathyroid diseases.
Tissue regeneration
The in vitro construction of glands for tissue regeneration is a promising approach for addressing glandular dysfunction caused by injury, disease, or aging [164]. One approach to glandular tissue regeneration is tissue engineering techniques, which involve the combination of cells, scaffolds, and signals to create functional tissue substitutes [165]. Tissue engineering glands incorporate the isolation and expansion of glandular cells, followed by the seeding of these cells onto a scaffold that mimics the architecture of the native gland [166]. The scaffold can be made from natural or synthetic materials with a design to provide mechanical support [167], promote cell adhesion and proliferation, and allow for the exchange of nutrients and waste products [168]. Several studies have successfully employed tissue engineering to regenerate different types of glands, including salivary glands, lacrimal glands, and mammary glands [169]. For example, researchers have used 3D printing technology to create customized hydrogel scaffolds that promote the formation of functional acinar units in cultured human salivary gland cells. Other approaches have involved the use of decellularized glandular tissue as a scaffold, which provides a natural microenvironment for seeded cells to regenerate functional glandular tissue.
In the field of tissue engineering, the reconstruction of appendage skin in both cultured cells and bioengineered transplants has shown promising results, particularly in the use of in vitro gland construction. The researchers developed a model to study how different glandular structures in human skin change during development (Fig. 14A) [170]. Among them, the hair follicle models can reproduce the same change process of hair follicles with that of human development. In addition, these cutaneous organs are periodically distributed throughout the epidermis, indicating the retention of accessory structure patterning mechanisms (Fig. 14B) [170]. However, after about 150 days of cultivation, accumulation of epithelial cells in the central part of the skin organ and abnormal morphology of hair follicles were observed, suggesting that this time point may represent the limit of skin organ cultivation. Implanting constructed skin organoids with hair into incisions on the backs of nude mice showed that 55% of the xenografts developed hair, although about 22% did not develop sweat glands. Nonetheless, skin organ models can be used to simulate a range of genetic skin diseases and cancers, providing a more complete tissue-engineered skin model for drug screening. In addition, by manipulating other cell lineages, these skin organoid models could be used to recreate skin tissue in burn or wound patients.
The majority of tear secretion, pivotal in preserving the stability of the ocular surface, is attributed to tear glands. Despite this, there remains limited insight into the diverse cell makeup and origins of tear fluid components. To enhance our comprehension of lacrimal gland disorders and unlock the prospects of regenerative therapies, it becomes imperative to cultivate fully developed human lacrimal gland epithelial cells. Addressing this need, Bannier-Helaouet and collaborators successfully initiated the development of lacrimal gland ductal organoids using both mouse and human tissue samples. Notably, these organoids demonstrated responsiveness to neurotransmitter stimulation and exhibited post-transplantation expansion (Fig. 14C) [171]. Tissue and organoid analysis through single-cell mRNA sequencing has brought to light the intricate cellular diversity within the lacrimal gland. This newly created organoid system stands poised as a potent screening tool for identifying agents that induce tear flow, given its propensity to elicit water secretion upon neurotransmitter exposure. However, it is important to note that the current organoid model predominantly mirrors the ductal segment of the tissue. To attain a more comprehensive grasp of acinar cell regeneration, further enhancements are requisite, particularly in the development of organoids derived from acinar cells. In vitro construction of glands for tissue regeneration shows promise as an approach for the treatment of glandular dysfunction. By combining tissue engineering techniques with advances in stem cell biology and biomaterials, researchers can create functional glandular substitutes that may one day be used to restore glandular function in patients with various glandular disorders.
Bioreactor
In vitro glands can be utilized in bioreactor systems to produce large quantities of functional glandular tissue for research, drug discovery, and therapeutic applications. Bioreactors provide a controlled environment in which cells and tissues can be cultured under conditions that mimic the in vivo microenvironment. One application of in vitro glands in bioreactors is in the production of glandular secretions for use in drug development and testing. For example, salivary glands can be cultured in bioreactors and stimulated to produce saliva, which can then be collected and used to test the efficacy of drugs designed to stimulate or inhibit salivary gland function.
The mammary gland bioreactor uses the mammary glands of transgenic animals to express genetically engineered medicinal proteins. It is currently the most widely used animal bioreactor with the most in-depth research, the most foreign protein production, and the earliest approval for commercial production in the world. The salivary glands of animals have the potential to be highly efficient bioreactors, because they can synthesize and secrete a variety of bioactive proteins into saliva throughout the animal's life. Salivary glands can specifically express some important exogenous protein factors and enzymes, such as nerve growth factor, so these exogenous target proteins can be obtained from the saliva of transgenic animals by constructing engineered salivary gland models. Zeng et al. employed the pig salivary gland as a bioreactor, using transformed pigs from gene editing technology. These transgenic pigs specifically express and secrete functional growth factor proteins at high levels in their salivary glands. Furthermore, they developed surgical and non-surgical methods to efficiently collect porcine saliva, and successfully isolated purified functional growth factor proteins from the collected saliva and confirmed their biological activities. This new approach to animal medicine holds promise for improving human health and biomedical research.
The snake venom gland, a specialized epithelial organ dedicated to toxin production, holds dual significance: not only does it fulfill its toxin-producing role, but it also serves as a valuable reservoir for identifying bioactive compounds with potential in drug development. Each year, millions of people endure snakebite-related complications. Nonetheless, snake venom also stands as a prolific source of bioactive molecules, acknowledged or potentially promising for therapeutic use. Organ-like structures that closely resemble the snake venom gland can be created from embryonic specimens or freshly obtained glands of adult snakes via biopsies. Biopsies collected from late-stage embryos, following removal from the egg, offer a reduced risk of bacterial contamination during culture, as opposed to organoids originating from early-stage adult snake biopsies in the developmental stages of new organ-like structures. The protocol has been successfully applied using both late-stage embryonic and recently deceased adult snake glands. The resulting organoids preserve the cellular diversity inherent to the venom gland and can be manipulated concerning cell-type composition by modifying the culture medium. Puschhof et al. [172] offer a comprehensive guide on how to derive and nurture these organoids, how to dissociate them into individual cells, and how to freeze-preserve and steer their differentiation into entities capable of toxin production (Fig. 15). Furthermore, comprehensive instructions are included for carrying out essential downstream analyses, encompassing quantitative real-time PCR, bulk and single-cell RNA sequencing, and immunofluorescence and immunohistochemistry techniques.
Personalized medicine
Cancer is a complex disease with considerable variation in staging, genetic background, and molecular behavior [173]. As an effective tool in capturing this heterogeneity, patient-derived organoids (PDOs) represent a more comprehensive model of human disease than a single genetic summary, providing a potential superior approach to clinical therapeutic decision-making compared to genomic guidance [174,175]. Patient-derived xenografts (PDXs) have been the specific model in cancer drug discovery and personalized medicine for decades [176]. They offer many benefits, including preservation of clonal architecture within tumors over repeated passaging, faithful recapitulation of patient drug response, and capture of genetic diversity of patient tumor types [177]. However, PDXs are both time-consuming and expensive, which greatly limit their further applications [178]. By contrast, PDOs offer superior cost-effectiveness, higher establishment success rates, and greater throughput. As larger-scale studies continue to establish the potential of PDOs in predicting drug responses and capturing patient heterogeneity, organoids are rapidly becoming one of the most powerful tools in our arsenal for simulating human physiology.
In recent years, preclinical breast cancer research has heavily relied on cell lines to represent a complex and diverse disease affecting millions of patients [179,180]. Despite being useful for high-throughput screening, breast cancer cell lines have limitations in capturing the full spectrum of breast cancer and are not clinically relevant for individual patients. Addressing this challenge, Sachs and colleagues have devised a remedy by formulating culture parameters for human breast epithelial organoids. Their efforts yielded a remarkable outcome: a collection of more than 100 primary and metastatic breast cancer organoid cell lines, effectively encapsulating the expansive spectrum of the disease's diversity (Fig. 16A to C) [181]. Importantly, the organoids exhibit no significant deviation from the original tumors in any aspect, even after prolonged passage. Using classical Cas9 gene editing, functional TP53 mutant clones were generated in the mammary organoids, which were largely retained. The breast cancer organoids managed to infiltrate all important gene expression-oriented classification frameworks. Moreover, they facilitated drug screening within an in vitro setting and mirrored patient responses that aligned seamlessly with outcomes observed in vivo, as corroborated by xenograft experiments. To demonstrate the predictive potential of breast cancer organoids, 2 organoid cell lines were selected and their differential responses to drugs that block signaling were examined. The results showed that breast cancer organoids responded to model drugs similar to in vivo models, successfully demonstrating the feasibility of using organoids to mimic glandular diseases.
Other applications
In vitro gland models can be used to study the biology of cancer and to develop new cancer therapies. For example, researchers can use in vitro models of prostate glands to study how prostate cancer cells interact with the surrounding tissue [182–184]. Interestingly, natural foods have shown potential in inhibiting cancer, and glandular models can be used to quickly screen their effects. For example, broccoli is a widely recognized vegetable for its nutritional value and chemoprotective potential [185]. In vitro models have been used to evaluate the effects of freeze-dried broccoli sprout extracts on normal and thyroid tumor cells, as well as their anti-inflammatory and antioxidant potential. To test the potential toxicity of broccoli sprout extract on normal nonneoplastic thyroid follicular epithelial cells, a preliminary in vitro assessment was conducted [185]. Results showed that even after prolonged exposure for up to 72 h, broccoli sprout extract was not toxic to non-neoplastic thyroid cells. This demonstrated the potential of broccoli sprouts to reduce thyroid cancer cell viability and prevented associated inflammation using an in vitro thyroid model.
Biomimetic bioartificial liver systems are emerging as a potential solution for end-stage liver disease, providing an alternative to liver transplantation [186,187]. This technology is similar to dialysis equipment for kidney disease patients, allowing for the exchange and renewal of metabolic waste back into the human body [188]. While still incomplete, this type of artificial liver system can offer patients with a bridge to transplantation for liver failure. Our team has developed a novel biomimetic bioartificial liver system by integrating microparticles and hollow fiber tubes loaded with stem-cell-derived hepatocytes into a miniaturized artificial liver platform [189]. This system mimics the functional unit of the human liver, the hepatic lobule, with microcarriers simulating the structure and semipermeable microtubules simulating large blood vessels. Compared to planar culture, experiments show that the cell retention rate on microcarriers is much higher and metabolic activity is enhanced. Further miniaturization of the equipment scale is expected to lead to better results, ultimately achieving a complete simulation of the human liver.
Conclusions and Future Perspectives
Less
In conclusion, biomimetic glandular models especially the glandular organoids have emerged as a powerful tool for recapitulating both the structural and functional aspects of glands in vitro. During the development process, stem cell research enables the utilization of ideal cell sources like patient-specific stem cells, while the microfluidic technique could provide a more realistic microenvironment for cell culture. Here, we have reviewed the progress of engineering strategies for accurate construction of gland models with similar structure, function, and microenvironment features to that of actual glands, from traditional 2D cell culture to novel organoid-on-a-chip technology. Based on different glandular models, their applications such as drug screening and disease modeling have been presented.
The development of organoid chip platforms for modeling glandular health and pathological phenotypes has been remarkable. However, their further advancement has been hindered by material complexity and safety concerns in their fabrication. The traditional photolithographic silicon technology suffers from the variability and inconsistency between different manufacturing lots and on-wafer capping models produced in different laboratories, while the commonly used polydimethylsiloxane (PDMS) poses a challenge in simulating the ECM environment of glands accurately. Therefore, it is essential to achieve a balance between safety and the need to create scalable, cost-effective commercial platforms, which may be realized by designing materials that can sufficiently mimic the complexity of natural substrates for controlling cell fate. Furthermore, to enable clinical use, it is crucial to identify materials that are free of any components derived from animals (Matrigel) and that can be fully characterized.
One of the primary concerns surrounding the development of gland models pertains to the creation of increasingly intricate glandular structures. While current models predominantly concentrate on relatively simple glandular tissues, such as the mammary gland or salivary gland, researchers are currently striving to fabricate more complex glandular tissue models, such as those of the pancreas, thyroid, and pituitary. This aspiration necessitates an accurate comprehension of the gland's biological growth and development processes from a biological perspective. Furthermore, a critical developmental domain is the adept integration of microfluidic systems into gland models, given their capacity to create more realistic tissue environments. The utilization of microfluidic systems enables researchers to analyze the effects of physical forces and chemical gradients on glandular tissues.
The utilization of 3D printing methods is expected to further advance the field of in vitro gland model development. A promising prospect for the application of 3D printing gland model development lies in its ability to generate models that faithfully replicate the structure and functionality of human glands. Additionally, 3D printing can facilitate the fabrication of gland models that are more intricate and elaborate than those generated by conventional methods. For instance, models that incorporate diverse cellular types and structures, or accurately mimic the glandular microenvironment, can be generated by 3D printing. It is anticipated that 3D printing technology will be increasingly leveraged in the future to create gland models that are more precise and tailored to individual patients, to be utilized in research and clinical field.
References
Less
1.
Kanczkowski W, Beuschlein F, Bornstein SR. Is there a role for the adrenal glands in long COVID? Nat Rev Endocrinol. 2022;18(8):451–452.
2.
Turcu AF, Yang J, Vaidya A. Primary aldosteronism—A multidimensional syndrome. Nat Rev Endocrinol. 2022;18(11):665–682.
3.
Yoon Y-J, Kim D, Tak KY, Hwang S, Kim J, Sim NS, Cho J-M, Choi D, Ji Y, Hur JK, et al.Salivary gland organoid culture maintains distinct glandular properties of murine and human major salivary glands. Nat Commun. 2022;13(1):3291.
4.
Khan S, Fitch S, Knox S, Arora R. Exocrine gland structure-function relationships. Development. 2022;149(1):Article 197657.
5.
Ebefors K, Lassen E, Anandakrishnan N, Azeloglu EU, Daehn SI. Modeling the glomerular filtration barrier and intercellular crosstalk. Front Physiol. 2021;12:Article 689083.
6.
Valverde MG, Mille LS, Figler KP, Cervantes E, Li VY, Bonventre JV, Masereeuw R, Zhang YS. Biomimetic models of the glomerulus. Nat Rev Nephrol. 2022;18(4):241–257.
7.
Zhang H, He Q, Wang J, Wang Y, Xuan X, Sui M, Zhang Z, Hou L. Biomimetic micelles to accurately regulate the inflammatory microenvironment for glomerulonephritis treatment. Pharmacol Res. 2022;181:Article 106263.
8.
Bulanova EA, Koudan EV, Degosserie J, Heymans C, Pereira FDAS, Parfenov VA, Sun Y, Wang Q, Akhmedova SA, Sviridova IK, et al.Bioprinting of a functional vascularized mouse thyroid gland construct. Biofabrication. 2017;9(3):Article 034105.
9.
Gokyurek M, Yilmaz KB, Yilgor Huri P. 3d bioprinting for the endocrine glands. Emergent Mater. 2020;3(4):441–452.
10.
Barillas-Mury C, Ribeiro JMC, Valenzuela JG. Understanding pathogen survival and transmission by arthropod vectors to prevent human disease. Science. 2022;377(6614):1507.
11.
Choa R, Tohyama J, Wada S, Meng H, Hu J, Okumura M, May RM, Robertson TF, Pai R-AL, Nace A, et al.Thymic stromal lymphopoietin induces adipose loss through sebum hypersecretion. Science. 2021;373(6554):532.
12.
Karthaus WR, Hofree M, Choi D, Linton EL, Turkekul M, Bejnood A, Carver B, Gopalan A, Abida W, Laudone V, et al.Regenerative potential of prostate luminal cells revealed by single-cell analysis. Science. 2020;368(6490):497.
13.
Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Fong CHY, Law CY, Leung EKH, To KKW, Tan KCB, et al.Thyroid dysfunction in relation to immune profile, disease status, and outcome in 191 patients with covid-19. J Clin Endocrinol Meta. 2021;106(2):E926–E935.
14.
Vojdani A, Vojdani E, Kharrazian D. Reaction of human monoclonal antibodies to sars-cov-2 proteins with tissue antigens: Implications for autoimmune diseases. Front Immunol. 2021;11:Article 617089.
15.
Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Luccarini C, Wahlstrom C, Pooley KA, Parsons MT, Fortuno C, Wang Q, et al.Breast cancer risk genes—Association analysis in more than 113, 000 women. N Engl J Med. 2021;384(5):428–439.
16.
Huang N, Perez P, Kato T, Mikami Y, Okuda K, Gilmore RC, Conde CD, Gasmi B, Stein S, Beach M, et al.SARS-CoV-2 infection of the oral cavity and saliva. Nat Med. 2021;27(5):892.
17.
Barrachina F, Battistone MA, Castillo J, Mallofre C, Jodar M, Breton S, Oliva R. Sperm acquire epididymis-derived proteins through epididymosomes. Hum Reprod. 2022;37(4):651–668.
18.
Boguslawska J, Godlewska M, Gajda E, Piekielko-Witkowska A. Cellular and molecular basis of thyroid autoimmunity. European Thyroid J. 2022;11(1):Article e210024.
19.
Eicher AK, Kechele DO, Sundaram N, Berns HM, Poling HM, Haines LE, Sanchez JG, Kishimoto K, Krishnamurthy M, Han L, et al.Functional human gastrointestinal organoids can be engineered from three primary germ layers derived separately from pluripotent stem cells. Cell Stem Cell. 2022;29(1):36.
20.
Michelson DA, Hase K, Kaisho T, Benoist C, Mathis D. Thymic epithelial cells co-opt lineage-defining transcription factors to eliminate autoreactive t cells. Cell. 2022;185(14):2542.
21.
Ingber DE. Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat Rev Genet. 2022;23(8):467–491.
22.
Mantovani A, Petracca G, Beatrice G, Csermely A, Lonardo A, Schattenberg JM, Tilg H, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: An updated meta-analysis. Gut. 2022;71(1):156–162.
23.
Cox N, Crozet L, Holtman IR, Loyher P-L, Lazarov T, White JB, Mass E, Stanley ER, Elemento O, Glass CK, et al.Diet-regulated production of pdgfcc by macrophages controls energy storage. Science. 2021;373(6550):Article 9383.
24.
Gosis BS, Wada S, Thorsheim C, Li K, Jung S, Rhoades JH, Yang Y, Brandimarto J, Li L, Uehara K, et al.Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC 1. Science. 2022;376(6590):264.
25.
Ashtonrickardt PG, Bandeira A, Delaney JR, Vankaer L, Pircher HP, Zinkernagel RM, Tonegawa S. Evidence for a differential avidity model of T-cell selection in the thymus. Cell. 1994;76(4):651–663.
26.
Edmondson R, Broglie JJ, Adcock AF, Yang L. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol. 2014;12(4):207–218.
27.
Clevers H. Modeling development and disease with organoids. Cell. 2016;165(7):1586–1597.
28.
McCracken KW, Cata EM, Crawford CM, Sinagoga KL, Schumacher M, Rockich BE, Tsai Y-H, Mayhew CN, Spence JR, Zavros Y, et al.Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature. 2014;516(7531):400.
29.
Laporte E, Nys C, Vankelecom H. Development of organoids from mouse pituitary as in vitro model to explore pituitary stem cell biology. Jove-J Visual Experi. 2022;180:Article e63431.
30.
Lee S, Chang J, Kang S-M, Parigoris E, Lee J-H, Huh YS, Takayama S. High-throughput formation and image-based analysis of basal-in mammary organoids in 384-well plates. Sci Rep. 2022;12(1):317.
31.
Kalot R, Mhanna R, Talhouk R. Organ-on-a-chip platforms as novel advancements for studying heterogeneity, metastasis, and drug efficacy in breast cancer. Pharmacol Ther. 2022;237:Article 108156.
32.
Keenan TM, Folch A. Biomolecular gradients in cell culture systems. Lab Chip. 2008;8(1):34–57.
33.
Shen H, Xue L, Ma Y, Huang H, Chen L. Recent advances toward wearable sweat monitoring systems. Adv Mater Technol. 2023;8(2):2200513.
34.
Yin Y, Vazquez-Rosado EJ, Farach A, Harrington DA. Microfluidics-based coaxial 3D bioprinting of hydrogels for salivary tissue engineering. Tissue Eng Part A. 2022;28:124–125.
35.
Bues J, Biocanin M, Pezoldt J, Dainese R, Chrisnandy A, Rezakhani S, Saelens W, Gardeux V, Gupta R, Sarkis R, et al.Deterministic scRNA-seq captures variation in intestinal crypt and organoid composition. Nat Methods. 2022;19(3):323.
36.
Ding S, Hsu C, Wang Z, Natesh NR, Millen R, Negrete M, Giroux N, Rivera GO, Dohlman A, Bose S, et al.Patient-derived micro-organospheres enable clinical precision oncology. Cell Stem Cell. 2022;29(6):905.
37.
Fang G, Lu H, Al-Nakashli R, Chapman R, Zhang Y, Ju LA, Lin G, Stenzel MH, Jin D. Enabling peristalsis of human colon tumor organoids on microfluidic chips. Biofabrication. 2022;14(1):Article 015006.
38.
Haque MR, Wessel CR, Leary DD, Wang C, Bhushan A, Bishehsari F. Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment. Microsyst Nanoeng. 2022;8(1):36.
39.
Rothbauer M, Ertl P. Emerging biosensor trends in organ-on-a-chip. Adv Biochem Eng Biotechnol. 2022;179:343–354.
40.
Leung CM, de Haan P, Ronaldson-Bouchard K, Kim G-A, Ko J, Rho HS, Chen Z, Habibovic P, Li Jeon N, Takayama S, et al.A guide to the organ-on-a-chip. Nat Rev Meth Primers. 2022;2(1):33.
41.
Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32(8):760–772.
42.
Plebani R, Potla R, Soong M, Bai H, Izadifar Z, Jiang A, Travis RN, Belgur C, Dinis A, Cartwright MJ, et al.Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip. J Cyst Fibros. 2022;21(4):606–615.
43.
Glaser DE, Curtis MB, Sariano PA, Rollins ZA, Shergill BS, Anand A, Deely AM, Shirure VS, Anderson L, Lowen JM, et al.Organ-on-a-chip model of vascularized human bone marrow niches. Biomaterials. 2022;280:Article 121245.
44.
Wadman M. FDA no longer has to require animal testing for new drugs. Science. 2023;379(6628):127–128.
45.
Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature. 2004;432(7015):332–337.
46.
Wang Y, Wang Z, Shao C, Lu G, Xie M, Wang J, Duan H, Li X, Yu W, Duan W, et al.Melatonin may suppress lung adenocarcinoma progression via regulation of the circular noncoding RNA hsa_circ_0017109/miR-135b-3p/TOX 3 axis. J Pineal Res. 2022;73(2):Article e12813.
47.
Lin Y, Dong S, Ye X, Liu J, Li J, Zhang Y, Tu M, Wang S, Ying Y, Chen R, et al.Synergistic regenerative therapy of thin endometrium by human placenta-derived mesenchymal stem cells encapsulated within hyaluronic acid hydrogels. Stem Cell Res Ther. 2022;13(1):66.
48.
Shen J, Ma M, Zhang H, Yu H, Xue F, Hao N, Chen H. Microfluidics-assisted surface trifunctionalization of a zeolitic imidazolate framework nanocarrier for targeted and controllable multitherapies of tumors. ACS Appl Mater Interfaces. 2020;12(41):45838–45849.
49.
Yao B, Wang R, Wang Y, Zhang Y, Hu T, Song W, Li Z, Huang S, Fu X. Biochemical and structural cues of 3D-printed matrix synergistically direct MSC differentiation for functional sweat gland regeneration. Sci Adv. 2020;6(10):eaaz 1094.
50.
Feng L, Hu Y-L, Ma P, Feng Y, Guo Y-B, Huang H, Li P, Mao Q-S, Xue W-J. Decellularized gastric matrix as a mesh for gastric perforation repair. J Biomed Mater Res Part B-Appli Biomater. 2021;109(3):451–462.
51.
van Tienderen GS, Rosmark O, Lieshout R, Willemse J, de Weijer F, Elowsson Rendin L, Westergren-Thorsson G, Doukas M, Groot Koerkamp B, van Royen ME, et al.Extracellular matrix drives tumor organoids toward desmoplastic matrix deposition and mesenchymal transition. Acta Biomater. 2023;158:115–131.
52.
Abbas Y, Brunel LG, Hollinshead MS, Fernando RC, Gardner L, Duncan I, Moffett A, Best S, Turco MY, Burton GJ, et al.Generation of a three-dimensional collagen scaffold-based model of the human endometrium. Interface Focus. 2020;10(2):20190079.
53.
Magalhaes RS, Williams JK, Yoo KW, Yoo JJ, Atala A. A tissue-engineered uterus supports live births in rabbits. Nat Biotechnol. 2020;38(11):1280.
54.
Hosseini M, Koehler KR, Shafiee A. Biofabrication of human skin with its appendages. Adv Healthc Mater. 2022;11(22):2201626.
55.
Oceguera-Yanez F, Avila-Robinson A, Woltjen K. Differentiation of pluripotent stem cells for modeling human skin development and potential applications. Front Cell Develop Biol. 2022;10:Article 1030339.
56.
Li J, Lin L, Zhong J, Li X, Lee C, Chiu PCN. Organoids as a model to study the human endometrium. Reprod Develop Med. 2022;6(4):215–224.
57.
Chen Y, Xu L, Li W, Chen W, He Q, Zhang X, Tang J, Wang Y, Liu B, Liu J. 3D bioprinted tumor model with extracellular matrix enhanced bioinks for nanoparticle evaluation. Biofabrication. 2022;14(2):Article 025002.
58.
Messelmani T, Morisseau L, Sakai Y, Legallais C, Le Goff A, Leclerc E, Jellali R. Liver organ-on-chip models for toxicity studies and risk assessment. Lab Chip. 2022;22(13):2423–2450.
59.
Huang DQ, Fu X, Zhang XX, Zhao YJ. Christmas tree-shaped microneedles as FOLFIRINOX spatiotemporal delivery system for pancreatic cancer treatment. Research. 2022;2022:Article 9809417.
60.
Yang W, Yue H, Lu G, Wang W, Deng Y, Ma G, Wei W. Advances in delivering oxidative modulators for disease therapy. Research. 2022;2022(9):7354700.
61.
Tcw J, Qian L, Pipalia NH, Chao MJ, Liang SA, Shi Y, Jain BR, Bertelsen SE, Kapoor M, Marcora E, et al.Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell. 2022;185(13):2213.
62.
Sies H, Belousov VV, Chandel NS, Davies MJ, Jones DP, Mann GE, Murphy MP, Yamamoto M, Winterbourn C. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nat Rev Mol Cell Biol. 2022;23(7):499–515.
63.
Gur C, Wang S-Y, Sheban F, Zada M, Li B, Kharouf F, Peleg H, Aamar S, Yalin A, Kirschenbaum D, et al.LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma. Cell. 2022;185(8):1373.
64.
Kimura I, Yamasoba D, Tamura T, Nao N, Suzuki T, Oda Y, Mitoma S, Ito J, Nasser H, Zahradnik J, et al.Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5. Cell. 2022;185(21):3992.
65.
Nawroth JC, Petropolis DB, Manatakis DV, Maulana TI, Burchett G, Schlunder K, Witt A, Shukla A, Kodella K, Ronxhi J, et al.Modeling alcohol-associated liver disease in a human liver-chip. Cell Rep. 2021;36(3):Article 109393.
66.
Shin W, Kim HJ. 3D in vitro morphogenesis of human intestinal epithelium in a gut-on-a-chip or a hybrid chip with a cell culture insert. Nat Protoc. 2022;17(3):910.
67.
Tsugami Y, Suzuki N, Kawahara M, Suzuki T, Nishimura T, Kobayashi K. Establishment of an in vitro culture model to study milk production and the blood-milk barrier with bovine mammary epithelial cells. Anim Sci J. 2020;91(1):Article e13355.
68.
Negrini NC, Volponi AA, Higgins CA, Sharpe PT, Celiz AD. Scaffold-based developmental tissue engineering strategies for ectodermal organ regeneration. Mater Today Bio. 2021;10:Article 100107.
69.
Kageyama T, Yoshimura C, Myasnikova D, Kataoka K, Nittami T, Maruo S, Fukuda J. Spontaneous hair follicle germ (HFG) formation in vitro, enabling the large-scale production of HFGs for regenerative medicine. Biomaterials. 2018;154:291–300.
70.
Su H, Yang F, Fu R, Trinh B, Sun N, Liu J, Kumar A, Baglieri J, Siruno J, Le M, et al.Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. Nature. 2022;610(7931):366.
71.
Drieu A, Du S, Storck SE, Rustenhoven J, Papadopoulos Z, Dykstra T, Zhong F, Kim K, Blackburn S, Mamuladze T, et al.Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid. Nature. 2022;611(7936):585.
72.
Yamanaka Y, Hamidi S, Yoshioka-Kobayashi K, Munira S, Sunadome K, Zhang Y, Kurokawa Y, Ericsson R, Mieda A, Thompson JL, et al.Reconstituting human somitogenesis in vitro. Nature. 2022;614:509.
73.
Huang J, Zhang W, Yu J, Gou Y, Liu N, Wang T, Sun C, Wu B, Li C, Chen X, et al.Human amniotic mesenchymal stem cells combined with PPCNg facilitate injured endometrial regeneration. Stem Cell Res Ther. 2022;13(1):17.
74.
Zou S, Yao X, Shao H, Reis RL, Kundu SC, Zhang Y. Nonmulberry silk fibroin-based biomaterials: Impact on cell behavior regulation and tissue regeneration. Acta Biomater. 2022;153:68–84.
75.
Sun J-Y, Zhao X, Illeperuma WRK, Chaudhuri O, Oh KH, Mooney DJ, Vlassak JJ, Suo Z. Highly stretchable and tough hydrogels. Nature. 2012;489(7414):133–136.
76.
Drury JL, Mooney DJ. Hydrogels for tissue engineering: Scaffold design variables and applications. Biomaterials. 2003;24(24):4337–4351.
77.
Peppas NA, Hilt JZ, Khademhosseini A, Langer R. Hydrogels in biology and medicine: From molecular principles to bionanotechnology. Adv Mater. 2006;18(11):1345–1360.
78.
John JV, McCarthy A, Wang H, Luo Z, Li H, Wang Z, Cheng F, Zhang YS, Xie J. Freeze-casting with 3D-printed templates creates anisotropic microchannels and patterned macrochannels within biomimetic nanofiber aerogels for rapid cellular infiltration. Adv Healthc Mater. 2021;10(12):2100238.
79.
Li Q, Qi G, Liu X, Bai J, Zhao J, Tang G, Zhang YS, Chen-Tsai R, Zhang M, Wang D, et al.Universal peptide hydrogel for scalable physiological formation and bioprinting of 3D spheroids from human induced pluripotent stem cells. Adv Funct Mater. 2021;31(41):2104046.
80.
Yuan XY, Duan XL, Enhejirigala Z, Li B, Yao W, Song YZ, Wang Y, Kong SJ, Zhu FL, Zhang F, et al.Reciprocal interaction between vascular niche and sweat gland promotes sweat gland regeneration. Bio Mater. 2023;21:340–357.
81.
Cai XL, Wang MM, Mu P, Jian TY, Liu D, Ding SC, Luo YA, Du D, Song Y, Chen CL, et al.Sequence-defined nanotubes assembled from IR780-conjugated peptoids for chemophototherapy of malignant glioma. Research. 2021;2021:Article 9861384.
82.
Yi XL, Duan QY, Wu FG. Low-temperature photothermal therapy: Strategies and applications. Research. 2021;2021:Article 9816594.
83.
Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669–676.
84.
Jang MS, Cai EN, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, et al.Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275(5297):218–220.
85.
Park SE, Georgescu A, Huh D. Organoids-on-a-chip. Science. 2019;364(6444):960–965.
86.
Sharma S, Bhatia V. Magnetic nanoparticles in microfluidics-based diagnostics: An appraisal. Nanomedicine. 2021;16(15):1329–1342.
87.
Battat S, Weitz DA, Whitesides GM. An outlook on microfluidics: The promise and the challenge. Lab Chip. 2022;22(3):530–536.
88.
Harofte SZ, Soltani M, Siavashy S, Raahemifar K. Recent advances of utilizing artificial intelligence in lab on a chip for diagnosis and treatment. Small. 2022;18(42):2203169.
89.
Cao T, Shao CM, Yu XY, Xie RP, Yang C, Sun YL, Yang SH, He WJ, Xu Y, Fan QH, et al.Biomimetic alveolus-on-a-chipfor SARS-CoV-2 infection recapitulation. Research. 2022;2022:Article 9819154.
90.
Arthur P, Muok L, Nathani A, Zeng EZ, Sun L, Li Y, Singh M. Bioengineering human pluripotent stem cell-derived retinal organoids and optic vesicle-containing brain organoids for ocular diseases. Cell. 2022;11(21):3429.
91.
Salmon I, Grebenyuk S, Fattah ARA, Rustandi G, Pilkington T, Verfaillie C, Ranga A. Engineering neurovascular organoids with 3D printed microfluidic chips. Lab Chip. 2022;22(8):1615–1629.
92.
Wang Q, Lu J, Fan K, Xu Y, Xiong Y, Sun Z, Zhai M, Zhang Z, Zhang S, Song Y, et al.High-throughput "read-on-ski" automated imaging and label-free detection system for toxicity screening of compounds using personalised human kidney organoids. J Zhejiang Univ-Sci B. 2022;23(7):564–577.
93.
Homan KA, Gupta N, Kroll KT, Kolesky DB, Skylar-Scott M, Miyoshi T, Mau D, Valerius MT, Ferrante T, Bonventre JV, et al.Flow-enhanced vascularization and maturation of kidney organoids in vitro. Nat Methods. 2019;16(3):255.
94.
Zhang X, Zhang Y, Zhang R, Jiang X, Midgley AC, Liu Q, Kang H, Wu J, Khalique A, Qian M, et al.Biomimetic design of artificial hybrid nanocells for boosted vascular regeneration in ischemic tissues. Adv Mater. 2022;34(14):Article 2110352.
95.
Liu X, Yang M, Lei F, Wang Y, Yang M, Mao C. Highly effective stroke therapy enabled by genetically engineered viral nanofibers. Adv Mater. 2022;34(20):Article 2201210.
96.
Yaman YI, Ramanathan S. Controlling human organoid symmetry breaking reveals signaling gradients drive segmentation clock waves. Cell. 2023;186(3):513–527.
97.
Uzquiano A, Kedaigle AJ, Pigoni M, Paulsen B, Adiconis X, Kim K, Faits T, Nagaraja S, Anton-Bolanos N, Gerhardinger C, et al.Proper acquisition of cell class identity in organoids allows definition of fate specification programs of the human cerebral cortex. Cell. 2022;185(20):3770.
98.
Thomson M. Spin glasses, error correcting codes, and synchronization of human stem cell organoids. Cell. 2023;186(3):461–463.
99.
Corsini NS, Knoblich JA. Human organoids: New strategies and methods for analyzing human development and disease. Cell. 2022;185(15):2756–2769.
100.
Allison SJ. Derivation of collecting duct organoids. Nat Rev Nephrol. 2022;18(12):743–743.
101.
Sharf T, van der Molen T, Glasauer SMK, Guzman E, Buccino AP, Luna G, Cheng Z, Audouard M, Ranasinghe KG, Kudo K, et al.Functional neuronal circuitry and oscillatory dynamics in human brain organoids. Nat Commun. 2022;13(1):4403.
102.
Tysoe O. Gene-edited organoids enable sensitive assessment of peptide hormone variation. Nat Rev Endocrinology. 2022;1:786.
103.
Camp JG, Treutlein B. Human brain organoids influence rat behaviour. Nature. 2022;610(7931):265–266.
104.
de Medeiros G, Ortiz R, Strnad P, Boni A, Moos F, Repina N, Meylan LC, Maurer F, Liberali P. Multiscale light-sheet organoid imaging framework. Nat Commun. 2022;13(1):4864.
105.
Burgess DJ. Organoids reveal the neurodevelopmental consequences of mutations. Nat Rev Genet. 2022;23(4):195–195.
106.
Hillion K, Mahe MM. Redesigning hydrogel geometry for enhanced organoids. Nat Methods. 2022;19(11):1347–1348.
107.
Watanabe S, Kobayashi S, Ogasawara N, Okamoto R, Nakamura T, Watanabe M, Jensen KB, Yui S. Transplantation of intestinal organoids into a mouse model of colitis. Nat Protoc. 2022;17(3):649.
108.
Hu WX, Lazar MA. Modelling metabolic diseases and drug response using stem cells and organoids. Nat Rev Endocrinol. 2022;18(12):744–759.
109.
Gjorevski N, Nikolaev M, Brown TE, Mitrofanova O, Brandenberg N, Del Rio FW, Yavitt FM, Liberali P, Anseth KS, Lutolf MP. Tissue geometry drives deterministic organoid patterning. Science. 2022;375(6576):40.
110.
Tanaka J, Senpuku H, Ogawa M, Yasuhara R, Ohnuma S, Takamatsu K, Watanabe T, Mabuchi Y, Nakamura S, Ishida S, et al.Author correction: Human induced pluripotent stem cell-derived salivary gland organoids model sars-cov-2 infection and replication. Nat Cell Biol. 2023;3:508–508.
111.
Bijnen M, Bajenoff M. Gland macrophages: Reciprocal control and function within their niche. Trends Immunol. 2021;42(2):120–136.
112.
Egalini F, Marinelli L, Rossi M, Motta G, Prencipe N, Giaccherino RR, Pagano L, Grottoli S, Giordano R. Endocrine disrupting chemicals: Effects on pituitary, thyroid and adrenal glands. Endocrine. 2022;78(3):395–405.
113.
Liu Y, Lyu Y, Wang H. Trp channels as molecular targets to relieve endocrine-related diseases. Front Mol Biosci. 2022;9:Article 895814.
114.
Burton GJ, Cindrova-Davies T, Yung HW, Jauniaux E. Oxygen and development of the human placenta. Reproduction. 2021;161(1):F53–F65.
115.
Coperchini F, Croce L, Ricci G, Magri F, Rotondi M, Imbriani M, Chiovato L. Thyroid disrupting effects of old and new generation PFAS. Front Endocrinol. 2021;11:Article 612320.
116.
Rahman HUU, Asghar W, Nazir W, Sandhu MA, Ahmed A, Khalid N. A comprehensive review on chlorpyrifos toxicity with special reference to endocrine disruption: Evidence of mechanisms, exposures and mitigation strategies. Sci Total Environ. 2021;755:Article 142649.
117.
Salvi M, Acharya UR, Molinari F, Meiburger KM. The impact of pre- and post-image processing techniques on deep learning frameworks: A comprehensive review for digital pathology image analysis. Comput Biol Med. 2021;128:Article 104129.
118.
Rawlings TM, Makwana K, Taylor DM, Mole MA, Fishwick KJ, Tryfonos M, Odendaal J, Hawkes A, Zernicka-Goetz M, Hartshorne GM, et al.Modelling the impact of decidual senescence on embryo implantation in human endometrial assembloids. elife. 2021;10:e69603.
119.
Verstappen GM, Kroese FGM, Bootsma H. T cells in primary Sjogren's syndrome: Targets for early intervention. Rheumatology. 2021;60(7):3088–3098.
120.
Yamaguchi M, Yoshihara K, Suda K, Nakaoka H, Yachida N, Ueda H, Sugino K, Mori Y, Yamawaki K, Tamura R, et al.Three-dimensional understanding of the morphological complexity of the human uterine endometrium. Iscience. 2021;24(4):Article 102258.
121.
Ogundipe VML, Plukker JTM, Links TP, Coppes RP. Thyroid gland organoids: Current models and insights for application in tissue engineering. Tissue Eng Part A. 2022;28(11-12):500–510.
122.
Romitti M, Tourneur A, da Fonseca BD, Doumont G, Gillotay P, Liao XH, Eski SE, Van Simaeys G, Chomette L, Lasolle H, et al.Transplantable human thyroid organoids generated from embryonic stem cells to rescue hypothyroidism. Nat Commun. 2022;13(1):7057.
123.
Abu-Bonsrah KD, Newgreen DF, Dottori M. Development of functional thyroid c cell-like cells from human pluripotent cells in 2D and in 3D scaffolds. Cell. 2021;10(11):2897.
124.
Cantley RL. Approach to fine needle aspiration of adrenal gland lesions. Adv Anat Pathol. 2022;29(6):373–379.
125.
Fitzek A, Gerling M, Puschel K, Saeger W. Post-mortem histopathology of pituitary and adrenals of COVID-19 patients. Legal Med. 2022;57:Article 102045.
126.
Kesrouani A, Abdallah W, Hatoum I, Khalil K, Nagib B, Choueiry E, Nasr B. Association between fetal adrenal gland ultrasound measurements in the 9th month and mode of delivery. American j perinatol. 2022;1:Article 35240701.
127.
Sun D, Wang J, Zhang K, Zhang H, Diao T, Fu Q. Adrenal gland metastasis of breast invasive mucinous carcinoma: A rare case report and review of literature. Case Rep Oncol. 2022;15(2):636–641.
128.
Suri S, Kour G, Sasan JS. Histomorphology and histochemistry of adrenal cortex of adult Bakerwali goat of Jammu region. J Livest Sci. 2022;13:80–87.
129.
Wang Y, Guo B, Guo Y, Qi N, Lv Y, Ye Y, Huang Y, Long X, Chen H, Su C, et al.A spatiotemporal steroidogenic regulatory network in human fetal adrenal glands and gonads. Front Endocrinol. 2022;13:Article 1036517.
130.
Poli G, Sarchielli E, Guasti D, Benvenuti S, Ballerini L, Mazzanti B, Armignacco R, Cantini G, Lulli M, Chortis V, et al.Human fetal adrenal cells retain age-related stem- and endocrine-differentiation potential in culture. FASEB J. 2019;33(2):2263–2277.
131.
Pryzhkova MV, Boers R, Jordan PW. Modeling human gonad development in organoids. Tissue Eng Regener Med. 2022;19(6):1185–1206.
132.
Ahn J, Yoon MJ, Hong SH, Cha H, Lee D, Koo HS, Ko JE, Lee J, Oh S, Li Jeon N, et al.Three-dimensional microengineered vascularised endometrium-on-a-chip. Hum Reprod. 2021;36(10):2720–2731.
133.
Zeleniak A, Wiegand C, Liu W, McCormick C, Ravikumar K, Alavi A, Guan HN, Bertera S, Lakomy R, Tajima A, et al.De novo construction of T cell compartment in humanized mice engrafted with IPSC-derived thymus organoids. Nat Methods. 2022;19(10):1306.
134.
Campinoti S, Gjinovci A, Ragazzini R, Zanieri L, Ariza-McNaughton L, Catucci M, Boeing S, Park J-E, Hutchinson JC, Munoz-Ruiz M, et al.Reconstitution of a functional human thymus by postnatal stromal progenitor cells and natural whole-organ scaffolds. Nat Commun. 2020;11(1):6372.
135.
Fan N, Zhao J, Zhao W, Shen Y, Song Q, Shum HC, Wang Y, Rong J. Biodegradable celastrol-loaded albumin nanoparticles ameliorate inflammation and lipid accumulation in diet-induced obese mice. Biomater Sci. 2022;10(4):984–996.
136.
Yuan H, Chao Y, Shum HC. Droplet and microchamber-based digital loop-mediated isothermal amplification (dLAMP). Small. 2020;16(9):Article 1904469.
137.
Campana L, Esser H, Huch M, Forbes S. Liver regeneration and inflammation: From fundamental science to clinical applications. Nat Rev Mol Cell Biol. 2021;22(9):608–624.
138.
Parlakgul G, Arruda AP, Pang S, Cagampan E, Min NN, Guney E, Lee GY, Inouye K, Hess HF, Xu CS, et al.Regulation of liver subcellular architecture controls metabolic homeostasis. Nature. 2022;603(7902):736.
139.
Cho H-J, Kim H-J, Lee K, Lasli S, Ung A, Hoffman T, Nasiri R, Bandaru P, Ahadian S, Dokmeci MR, et al.Bioengineered multicellular liver microtissues for modeling advanced hepatic fibrosis driven through non-alcoholic fatty liver disease. Small. 2021;17(14):Article 2007425.
140.
Hajiabbas M, D'Agostino C, Siminska-Stanny J, Tran SD, Shavandi A, Delporte C. Bioengineering in salivary gland regeneration. J Biomed Sci. 2022;29(1):35.
141.
Tanaka J, Senpuku H, Ogawa M, Yasuhara R, Ohnuma S, Takamatsu K, Watanabe T, Mabuchi Y, Nakamura S, Ishida S, et al.Human induced pluripotent stem cell-derived salivary gland organoids model sars-cov-2 infection and replication. Nat Cell Biol. 2022;24(11):1595.
142.
Lee J, van der Valk WH, Serdy SA, Deakin C, Kim J, Le AP, Koehler KR. Generation and characterization of hair-bearing skin organoids from human pluripotent stem cells. Nat Protoc. 2022;17(5):1266–1305.
143.
Sun X, Xiang J, Chen R, Geng Z, Wang L, Liu Y, Ji S, Chen H, Li Y, Zhang C, et al.Sweat gland organoids originating from reprogrammed epidermal keratinocytes functionally recapitulated damaged skin. Adv Sci. 2021;8(22):Article 2103079.
144.
Rosenbluth JM, Schackmann RCJ, Gray GK, Selfors LM, Li CMC, Boedicker M, Kuiken HJ, Richardson A, Brock J, Garber J, et al.Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages. Nat Commun. 2020;11(1):1711.
145.
Nelson CM, Van Duijn MM, Inman JL, Fletcher DA, Bissell MJ. Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science. 2006;314(5797):298–300.
146.
Buchmann B, Engelbrecht LK, Fernandez P, Hutterer FP, Raich MK, Scheel CH, Bausch AR. Mechanical plasticity of collagen directs branch elongation in human mammary gland organoids. Nat Commun. 2021;12(1):2759.
147.
Fernandez PA, Buchmann B, Goychuk A, Engelbrecht LK, Raich MK, Scheel CH, Frey E, Bausch AR. Surface-tension-induced budding drives alveologenesis in human mammary gland organoids. Nat Phys. 2021;17(10):1130.
148.
Jiang X, Chen C, Liu J, Liu S. Application value of mathematical models of diffusion-weighted magnetic resonance imaging in differentiating breast cancer lesions. Evid Based Complement Alternat Med. 2021;2021:Article 1481271.
149.
Pillai S, Munguia-Lopez JG, Tran SD. Hydrogels for salivary gland tissue engineering. Gels. 2022;8(11):730.
150.
Rodboon T, Souza G, Mutirangura A, Ferreira J. Magnetic bioassembly platforms for establishing craniofacial exocrine gland organoids as aging in vitro models. PLoS One. 2022;17(8):Article e0272644.
151.
Tang ZM, Kong N, Zhang XC, Liu Y, Hu P, Mou S, Liljestrom P, Shi JL, Tan WH, Kim JS, et al.A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847–860.
152.
Yang LL, Han YL, Nilsson-Payant BE, Gupta V, Wang PF, Duan XH, Tang XM, Zhu JJ, Zhao ZP, Jaffre F, et al.A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell. 2020;27(1):125.
153.
Kutys ML, Polacheck WJ, Welch MK, Gagnon KA, Koorman T, Kim S, Li LQ, McClatchey AI, Chen CS. Uncovering mutation-specific morphogenic phenotypes and paracrine-mediated vessel dysfunction in a biomimetic vascularized mammary duct platform. Nat Commun. 2020;11(1):3377.
154.
Fan X-Y, Deng Z-F, Yan Y-Y, Orel VE, Shypko A, Orel VB, Ivanova D, Pilarsky C, Tang J, Chen Z-S, et al.Application of microfluidic chips in anticancer drug screening. Bosn J Basic Med Sci. 2022;22(3):302–314.
155.
Kravitz E, Suh M, Russell M, Ojeda A, Levison J, McKinney J. Screening for substance use disorders during pregnancy: A decision at the intersection of racial and reproductive justice. Am J Perinatol. 2021;40:598–601.
156.
Pope JD, Black MJ, Drummer OH, Schneider HG. Urine toxicology screening by liquid chromatography time-of-flight mass spectrometry in a quaternary hospital setting. Clin Biochem. 2021;95:66–72.
157.
Shelton D. Fentanyl not detected in routine urine drug screens: Case report. Canadian J Emerg Med. 2022;24(3):335–336.
158.
Winchester M-L, Shahiri P, Boevers-Solverson E, Hartmann A, Ross M, Fitzgerald S, Parrish M. Racial and ethnic differences in urine drug screening on labor and delivery. Matern Child Health J. 2022;26(1):124–130.
159.
Al Reza H, Okabe R, Takebe T. Organoid transplant approaches for the liver. Transpl Int. 2021;34(11):2031–2045.
160.
Marsee A, Roos FJM, Verstegen MMA, Gehart H, de Koning E, Lemaigre F, Forbes SJ, Peng WC, Huch M, Takebe T, et al.Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids. Cell Stem Cell. 2021;28(5):816–832.
161.
Rezakhani S, Gjorevski N, Lutolf MP. Extracellular matrix requirements for gastrointestinal organoid cultures. Biomaterials. 2021;276:Article 121020.
162.
Song YH, Uchida H, Sharipol A, Piraino L, Mereness JA, Ingalls MH, Rebhahn J, Newlands SD, DeLouise LA, Ovitt CE, et al.Development of a functional salivary gland tissue chip with potential for high-content drug screening. Commun Biol. 2021;4(1):361.
163.
Noltes ME, Sondorp LHJ, Kracht L, Antunes IF, Wardenaar R, Kelder W, Kemper A, Szymanski W, Zandee WT, Jansen L, et al.Patient-derived parathyroid organoids as a tracer and drug-screening application model. Stem Cell Reports. 2022;17(11):2518–2530.
164.
Owida HA, Al-Nabulsi JI, Alnaimat F, Al-Ayyad M, Turab NM, Al Sharah A, Shakur M. Recent applications of electrospun nanofibrous scaffold in tissue engineering. Appli Bio Biomech. 2022;2022:Article 1953861.
165.
Tao C, Wang D-A. Tissue engineering for mimics and modulations of immune functions. Adv Healthc Mater. 2021;10(12):Article 2100146.
166.
Tavakol DN, Fleischer S, Falcucci T, Graney PL, Halligan SP, Kaplan DL, Vunjak-Novakovic G. Emerging trajectories for next generation tissue engineers. ACS Biomater Sci Eng. 2021;1:Article 1428.
167.
Zhao CQ, Zhang PC, Zhou JJ, Qi SH, Yamauchi Y, Shi RR, Fang RC, Ishida Y, Wang ST, Tomsia AP, et al.Layered nanocomposites by shear-flow-induced alignment of nanosheets. Nature. 2020;580(7802):210.
168.
Xue W, Du J, Li Q, Wang Y, Lu Y, Fan J, Yu S, Yang Y. Preparation, properties, and application of graphene-based materials in tissue engineering scaffolds. Tissue Eng Part B-Rev. 2022;1:127.
169.
Zheng X, Zhang P, Fu Z, Meng S, Dai L, Yang H. Applications of nanomaterials in tissue engineering. RSC Adv. 2021;11(31):19041–19058.
170.
Lee JY, Rabbani CC, Gao HY, Steinhart MR, Woodruff BM, Pflum ZE, Kim A, Heller S, Liu YL, Shipchandler TZ, et al.Hair-bearing human skin generated entirely from pluripotent stem cells. Nature. 2020;582(7812):399.
171.
Bannier-Helaouet M, Post Y, Korving J, Bustos MT, Gehart H, Begthel H, Bar-Ephraim YE, van der Vaart J, Kalmann R, Imhoff SM, et al.Exploring the human lacrimal gland using organoids and single-cell sequencing. Cell Stem Cell. 2021;28(7):1221.
172.
Puschhof J, Post Y, Beumer J, Kerkkamp HM, Bittenbinder M, Vonk FJ, Casewell NR, Richardson MK, Clevers H. Derivation of snake venom gland organoids for in vitro venom production. Nat Protoc. 2021;16(3):1494–1510.
173.
Saeki S, Kumegawa K, Takahashi Y, Yang L, Osako T, Yasen M, Otsuji K, Miyata K, Yamakawa K, Suzuka J, et al.Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin. Breast Cancer Res. 2023;25(1):21.
174.
Hao M, Cao Z, Wang Z, Xin J, Kong B, Xu J, Zhang L, Chen P.Patient-derived organoid model in the prediction of chemotherapeutic drug response in colorectal cancer. ACS Biomater Sci Eng. 2022;1:354.
175.
Luo X, Fong ELS, Zhu C, Lin QXX, Xiong M, Li A, Li T, Benoukraf T, Yu H, Liu S. Hydrogel-based colorectal cancer organoid co-culture models. Acta Biomater. 2021;132:461–472.
176.
du Manoir S, Orsetti B, Bras-Goncalves R, Tien-Tuan N, Lasorsa L, Boissiere F, Massemin B, Colombo P-E, Bibeau F, Jacot W, et al.Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse. Mol Oncol. 2014;8(2):431–443.
177.
Lawrence MG, Taylor RA, Cuffe GB, Ang LS, Clark AK, Goode DL, Porter LH, Le Magnen C, Navone NM, Schalken JA, et al.The future of patient-derived xenografts in prostate cancer research. Nat Rev Urol. 2023;20(6):371–384.
178.
Mondal AM, Ma A-H, Li G, Krawczyk E, Yuan R, Lu J, Schlegel R, Stamatakis L, Kowalczyk KJ, Philips GK, et al.Fidelity of a PDX-CR model for bladder cancer. Biochem Biophys Res Commun. 2019;517(1):49–56.
179.
He J, Chen C, Chen L, Cheng R, Sun J, Liu X, Wang L, Zhu C, Hu S, Xue Y, et al.Honeycomb-like hydrogel microspheres for 3D bulk construction of tumor models. Research. 2022;2022(2022):Article 9809763.
180.
Wang H, Guo J, Lin W, Fu Z, Ji X, Yu B, Lu M, Cui W, Deng L, Engle JW, et al.Open-shell nanosensitizers for glutathione responsive cancer sonodynamic therapy. Adv Mater. 2022;34(15):Article 2110283.
181.
Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, Balgobind AV, Wind K, Gracanin A, Begthel H, et al.A living biobank of breast cancer organoids captures disease heterogeneity. Cell. 2018;172(1-2):373.
182.
Bazzi LA, Sigurdardottir LG, Sigurdsson S, Valdimarsdottir U, Torfadottir J, Aspelund T, Czeisler CA, Lockley SW, Jonsson E,Launer L, et al.Exploratory assessment of pineal gland volume, composition, and urinary 6-sulfatoxymelatonin levels on prostate cancer risk. Prostate. 2021;81(8):487–496.
183.
Heynickx N, Herrmann K, Vermeulen K, Baatout S, Aerts A. The salivary glands as a dose limiting organ of PSMA-targeted radionuclide therapy: A review of the lessons learnt so far. Nucl Med Biol. 2021;98-99:30–39.
184.
John J, Ravikumar A, Abraham B. Prostate cancer prediction from multiple pretrained computer vision model. Heal Technol. 2021;11(5):1003–1011.
185.
Pasko P, Zagrodzki P, Okon K, Prochownik E, Krosniak M, Galanty A. Broccoli sprouts and their influence on thyroid function in different in vitro and in vivo models. Plants-Basel. 2022;11(20):2750.
186.
Morelli S, Piscioneri A, Salerno S, De Bartolo L. Hollow fiber and nanofiber membranes in bioartificial liver and neuronal tissue engineering. Cells Tissues Organs. 2022;211(4):447–476.
187.
Zhang J, Zhao X, Liang L, Li J, Demirci U, Wang S. A decade of progress in liver regenerative medicine. Biomaterials. 2018;157(161):–176.
188.
Guo L, Zhu Z, Gao C, Chen K, Lu S, Yan H, Liu W, Wang M, Ding Y, Huang L, et al.Development of biomimetic hepatic lobule-like constructs on silk-collagen composite scaffolds for liver tissue engineering. Front Bioeng Biotechnol. 2022;10:Article 940634.
189.
Wang JL, Ren HZ, Liu YX, Sun LY, Zhang ZH, Zhao YJ, Shi XL. Bioinspired artificial liver system with hiPSC-derived hepatocytes for acute liver failure treatment. Adv Healthc Mater. 2021;10(23):Article 2101580.
190.
Ogawa M, Oshima M, Imamura A, Sekine Y, Ishida K, Yamashita K, Nakajima K, Hirayama M, Tachikawa T, Tsuji T. Functional salivary gland regeneration by transplantation of a bioengineered organ germ. Nat Commun. 2013;4:Article 2498.
Appendix
Less
Year 2023 volume 6 Issue 9
PDF
35
20
Cite this Article
BibTeX
Article Info
doi: 10.34133/research.0232
  • Receive Date：2023-06-30
  • Online Date：2026-10-28
  • Published：2023-09-20
Article Data
Affiliations
History
  • Received：2023-06-30
  • Accepted：2023-08-29
Affiliations
    1Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.
    2Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang 325001, China.
    3Southeast University Shenzhen Research Institute, Shenzhen 518071, China.

Corresponding:

* Address correspondence to:
References
Share
https://castjournals.cast.org.cn/joweb/research/EN/10.34133/research.0232
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House